401 related articles for article (PubMed ID: 1988125)
1. Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy.
Thomassen MJ; Ahmad M; Barna BP; Antal J; Wiedemann HP; Meeker DP; Klein J; Bauer L; Gibson V; Andresen S
Cancer Res; 1991 Feb; 51(3):857-62. PubMed ID: 1988125
[TBL] [Abstract][Full Text] [Related]
2. Differential effect of recombinant granulocyte macrophage colony-stimulating factor on human monocytes and alveolar macrophages.
Thomassen MJ; Barna BP; Rankin D; Wiedemann HP; Ahmad M
Cancer Res; 1989 Aug; 49(15):4086-9. PubMed ID: 2545332
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of macrophage- and granulocyte-macrophage colony-stimulating factors on cytokine gene expression during rat alveolar macrophage differentiation into multinucleated giant cells (MGC): role for IL-6 in type 2 MGC formation.
Lemaire I; Yang H; Lafont V; Dornand J; Commes T; Cantin MF
J Immunol; 1996 Dec; 157(11):5118-25. PubMed ID: 8943422
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human blood monocyte and alveolar macrophage inflammatory cytokine production by nitric oxide.
Dinakar C; Malur A; Raychaudhuri B; Buhrow LT; Melton AL; Kavuru MS; Thomassen MJ
Ann Allergy Asthma Immunol; 1999 Feb; 82(2):217-22. PubMed ID: 10071528
[TBL] [Abstract][Full Text] [Related]
5. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
6. Recombinant granulocyte-macrophage colony-stimulating factor down-regulates expression of IL-2 receptor on human mononuclear phagocytes by induction of prostaglandin E.
Hancock WW; Pleau ME; Kobzik L
J Immunol; 1988 May; 140(9):3021-5. PubMed ID: 3129507
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration.
Kleinerman ES; Knowles RD; Lachman LB; Gutterman JU
Cancer Res; 1988 May; 48(9):2604-9. PubMed ID: 3128401
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tumor necrosis factor-alpha production and gene expression in monocytes.
Kohn FR; Phillips GL; Klingemann HG
Bone Marrow Transplant; 1992 May; 9(5):369-76. PubMed ID: 1617321
[TBL] [Abstract][Full Text] [Related]
9. Cytokine expression from bone marrow derived macrophages.
Temeles DS; McGrath HE; Kittler EL; Shadduck RK; Kister VK; Crittenden RB; Turner BL; Quesenberry PJ
Exp Hematol; 1993 Feb; 21(2):388-93. PubMed ID: 7678817
[TBL] [Abstract][Full Text] [Related]
10. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures.
Dimri R; Nissimov L; Keisari Y
Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor expression is regulated at transcriptional and posttranscriptional levels in a murine bone marrow stromal cell line.
Derigs HG; Reifel-Miller A; Kaushansky K; Hromas RA; Boswell HS
Exp Hematol; 1994 Aug; 22(9):924-32. PubMed ID: 8062890
[TBL] [Abstract][Full Text] [Related]
12. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
13. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
14. Taxol induces the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor in murine B-cells by stabilization of granulocyte-macrophage colony-stimulating factor nuclear RNA.
Pluznik DH; Lee NS; Sawada T
Cancer Res; 1994 Aug; 54(15):4150-4. PubMed ID: 7913412
[TBL] [Abstract][Full Text] [Related]
15. Differential production of tumor necrosis factor, macrophage colony stimulating factor, and interleukin 1 by human alveolar macrophages.
Becker S; Devlin RB; Haskill JS
J Leukoc Biol; 1989 Apr; 45(4):353-61. PubMed ID: 2649630
[TBL] [Abstract][Full Text] [Related]
16. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
[TBL] [Abstract][Full Text] [Related]
17. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.
Janson RW; Hance KR; Arend WP
J Immunol; 1991 Dec; 147(12):4218-23. PubMed ID: 1836481
[TBL] [Abstract][Full Text] [Related]
18. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
19. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha.
Alvaro-Gracia JM; Zvaifler NJ; Brown CB; Kaushansky K; Firestein GS
J Immunol; 1991 May; 146(10):3365-71. PubMed ID: 2026869
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
